Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes

被引：0
|
作者：
Takashi Nishimura
Satoru Iwasa
Kengo Nagashima
Natsuko Okita
Atsuo Takashima
Yoshitaka Honma
Ken Kato
Tetsuya Hamaguchi
Yasuhide Yamada
Yasuhiro Shimada
Narikazu Boku
机构：
[1] National Cancer Center Hospital,Gastrointestinal Medical Oncology Division
[2] The Jikei University School of Medicine,Department of Gastroenterology and Hepatology
[3] Chiba University,Department of Global Clinical Research, Graduate School of Medicine
来源：
Gastric Cancer | 2017年 / 20卷
关键词：
Irinotecan; Third-line chemotherapy; Gastric cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：655 / 662
页数：7
相关论文
共 50 条
  • [41] Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer
    Seong Yoon Yi
    Young Suk Park
    Hyo Song Kim
    Hyun Jung Jun
    Kyoung Ha Kim
    Myung Hee Chang
    Min Jae Park
    Ji Eun Uhm
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Jong Kyun Lee
    Kyu Taek Lee
    Ho Yeong Lim
    Won Ki Kang
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 63 : 1141 - 1145
  • [42] Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer
    Park, Y.
    Yi, S.
    Kim, H.
    Lee, S.
    Hwang, I.
    Park, S.
    Park, B.
    Park, J.
    Lim, H.
    Kang, W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [43] Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer
    Yi, Seong Yoon
    Park, Young Suk
    Kim, Hyo Song
    Jun, Hyun Jung
    Kim, Kyoung Ha
    Chang, Myung Hee
    Park, Min Jae
    Uhm, Ji Eun
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Lee, Jong Kyun
    Lee, Kyu Taek
    Lim, Ho Yeong
    Kang, Won Ki
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1141 - 1145
  • [44] Third-line chemotherapy with paclitaxel, irinotecan hydrochloride and cisplatin for recurrent gastric cancer: A case report
    Takahashi, N
    Suzuki, H
    Iwabuchi, S
    Yamazaki, Y
    Yanaga, K
    [J]. HEPATO-GASTROENTEROLOGY, 2005, 52 (61) : 326 - 328
  • [45] Taxanes in the Treatment of Advanced Gastric Cancer
    Kang, Byung Woog
    Kwon, Oh-Kyoung
    Chung, Ho Young
    Yu, Wansik
    Kim, Jong Gwang
    [J]. MOLECULES, 2016, 21 (05)
  • [46] Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer
    Hyun Jeong Shim
    Ju Young Yun
    Jun Eul Hwang
    Woo Kyun Bae
    Sang Hee Cho
    Ik Joo Chung
    [J]. Gastric Cancer, 2011, 14 : 249 - 256
  • [47] Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer
    Shim, Hyun Jeong
    Yun, Ju Young
    Hwang, Jun Eul
    Bae, Woo Kyun
    Cho, Sang Hee
    Chung, Ik Joo
    [J]. GASTRIC CANCER, 2011, 14 (03) : 249 - 256
  • [48] Irinotecan combined with Panitumumab or cetuximab as third-line treatment for metastatic colorectal cancer.
    Braghiroli, Maria Ignez
    Batistuzzo Vicentini, Maria Fernanda
    da Fonseca, Leonardo Gomes
    Souza, Karla Teixeira
    Bonadio, Renata Colombo
    Melro Braghiroli, Oddone Freitas
    Machado Mathias, Maria Cecilia
    Talans, Aley
    Zambrano Mendoza, Maria Elizabeth
    Martins, Juliana Goes
    Sabagga, Jorge
    Motta Venchiarutti Moniz, Camila Venchiarutti
    Hoff, Paulo Marcelo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15551 - E15551
  • [49] Prognostic factor for third-line chemotherapy in patients with advanced gastric cancer.
    Choi, Jonggwon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [50] Apatinib combined with PD-1 antibody for third-line or later treatment of advanced gastric cancer
    Cui, Qingli
    Mao, Yuefeng
    Wu, Daoyuan
    Hu, Yanhui
    Ma, Dongyang
    Zhang, LiHan
    Liu, Huaimin
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
12345